Hemodialysis Machines Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Hemodialysis machines are intended to pump blood, monitor the blood flow for safety, clean wastes from the blood and monitor blood pressure and the rate of fluid removal from the body. One unit refers to one hemodialysis machine. GlobalData’s Medical Devices sector report, “Hemodialysis Machines – Medical Devices Pipeline Product Landscape, 2021″ provides comprehensive information about the Hemodialysis Machines pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Hemodialysis Machines report provides key information and data related to:
Extensive coverage of the Hemodialysis Machines under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Hemodialysis Machines pipeline products.
Review of Recent Developments in the segment / industry
The Hemodialysis Machines report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Hemodialysis Machines under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies’ revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Hemodialysis Machines under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Hemodialysis Machines and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

– Identify and understand important and diverse types of Hemodialysis Machines under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

AngioDynamics Inc
Asahi Kasei Medical Co Ltd
AWAK Technologies Pte Ltd
Blood Purification Technologies, Inc.
Chemica Technologies Inc
CVS Kidney Care
Diality Inc
Fresenius Medical Care Holdings Inc
Gambro Dasco SpA
Georgia Institute of Technology
Infomed SA
Iowa State University
Medtronic Plc
Nanodialysis BV
Neokidney Development BV
Nephria Bio Inc
Nikkiso Co Ltd
NxStage Medical Inc
Physiologas Technologies Inc
Quanta Dialysis Technologies Ltd
University of Rostock
University of Saskatchewan
Vanderbilt University
Vivonics Inc
Vizio Medical Devices
Wearable Artificial Organs Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Hemodialysis Machines Overview 8

3 Products under Development 9

3.1 Hemodialysis Machines – Pipeline Products by Stage of Development 9

3.2 Hemodialysis Machines – Pipeline Products by Segment 10

3.3 Hemodialysis Machines – Pipeline Products by Territory 11

3.4 Hemodialysis Machines – Pipeline Products by Regulatory Path 12

3.5 Hemodialysis Machines – Pipeline Products by Estimated Approval Date 13

3.6 Hemodialysis Machines – Ongoing Clinical Trials 14

4 Hemodialysis Machines – Pipeline Products under Development by Companies 15

4.1 Hemodialysis Machines Companies – Pipeline Products by Stage of Development 15

4.2 Hemodialysis Machines – Pipeline Products by Stage of Development 16

5 Hemodialysis Machines Companies and Product Overview 17

5.1 AngioDynamics Inc Company Overview 17

5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 Asahi Kasei Medical Co Ltd Company Overview 18

5.2.1 Asahi Kasei Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 AWAK Technologies Pte Ltd Company Overview 19

5.3.1 AWAK Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 Blood Purification Technologies, Inc. Company Overview 20

5.4.1 Blood Purification Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 Chemica Technologies Inc Company Overview 21

5.5.1 Chemica Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 CVS Kidney Care Company Overview 22

5.6.1 CVS Kidney Care Pipeline Products & Ongoing Clinical Trials Overview 22

5.7 Diality Inc Company Overview 25

5.7.1 Diality Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.8 Fresenius Medical Care Holdings Inc Company Overview 26

5.8.1 Fresenius Medical Care Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 Gambro Dasco SpA Company Overview 29

5.9.1 Gambro Dasco SpA Pipeline Products & Ongoing Clinical Trials Overview 29

5.10 Georgia Institute of Technology Company Overview 30

5.10.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 30

5.11 Infomed SA Company Overview 32

5.11.1 Infomed SA Pipeline Products & Ongoing Clinical Trials Overview 32

5.12 Iowa State University Company Overview 35

5.12.1 Iowa State University Pipeline Products & Ongoing Clinical Trials Overview 35

5.13 Medtronic Plc Company Overview 36

5.13.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 36

5.14 Nanodialysis BV Company Overview 37

5.14.1 Nanodialysis BV Pipeline Products & Ongoing Clinical Trials Overview 37

5.15 Neokidney Development BV Company Overview 38

5.15.1 Neokidney Development BV Pipeline Products & Ongoing Clinical Trials Overview 38

5.16 Nephria Bio Inc Company Overview 39

5.16.1 Nephria Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.17 Nikkiso Co Ltd Company Overview 40

5.17.1 Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

5.18 NxStage Medical Inc Company Overview 42

5.18.1 NxStage Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.19 Physiologas Technologies Inc Company Overview 43

5.19.1 Physiologas Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.20 Quanta Dialysis Technologies Ltd Company Overview 44

5.20.1 Quanta Dialysis Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

5.21 University of Rostock Company Overview 45

5.21.1 University of Rostock Pipeline Products & Ongoing Clinical Trials Overview 45

5.22 University of Saskatchewan Company Overview 46

5.22.1 University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview 46

5.23 Vanderbilt University Company Overview 47

5.23.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 47

5.24 Vivonics Inc Company Overview 48

5.24.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.25 Vizio Medical Devices Company Overview 49

5.25.1 Vizio Medical Devices Pipeline Products & Ongoing Clinical Trials Overview 49

5.26 Wearable Artificial Organs Inc Company Overview 50

5.26.1 Wearable Artificial Organs Inc Pipeline Products & Ongoing Clinical Trials Overview 50

6 Hemodialysis Machines- Recent Developments 51

6.1 Oct 13, 2021: Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference 51

6.2 Sep 27, 2021: Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors 51

6.3 Jul 30, 2021: Fresenius Medical Care reports results in line with expectations for the second quarter and confirms 2021 outlook 51

6.4 Jul 29, 2021: Baxter Reports Second-Quarter 2021 Results 54

6.5 Jul 29, 2021: Baxter to Present at UBS Genomics

2.0 and MedTech Innovations Summit 56

6.6 Jun 30, 2021: Asahi Kasei Announces Q1 2021 Financial Results 56

6.7 Jun 15, 2021: Baxter to Host Second-Quarter 2021 Financial Results Conference Call for Investors 57

6.8 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences 57

6.9 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021 57

6.10 Feb 12, 2021: QUANTA Appoints Dr Selwayan Saini as Chief Operating Officer 58

6.11 Feb 12, 2021: Asahi Intecc announces financial results and presentation materials for the 2nd Quarter of the fiscal year ending June 2021 58

6.12 Feb 01, 2021: Asahi Holdings Australia appoints new Chairman 58

6.13 Jan 21, 2021: Baxter to Present at SVB Leerink 10th Annual Global Healthcare Conference 59

7 Appendix 60

7.1 Methodology 60

7.2 About GlobalData 63

7.3 Contact Us 63

Table

Hemodialysis Machines – Pipeline Products by Stage of Development 9

Hemodialysis Machines – Pipeline Products by Segment 10

Hemodialysis Machines – Pipeline Products by Territory 11

Hemodialysis Machines – Pipeline Products by Regulatory Path 12

Hemodialysis Machines – Pipeline Products by Estimated Approval Date 13

Hemodialysis Machines – Ongoing Clinical Trials 14

Hemodialysis Machines Companies – Pipeline Products by Stage of Development 15

Hemodialysis Machines – Pipeline Products by Stage of Development 16

AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 17

Next Generation Dialysis Device – Product Status 17

Next Generation Dialysis Device – Product Description 17

Asahi Kasei Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 18

APS Polysulfone-membrane Artificial Kidney – New Version – Product Status 18

APS Polysulfone-membrane Artificial Kidney – New Version – Product Description 18

AWAK Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

AWAK HD – Product Status 19

AWAK HD – Product Description 19

Blood Purification Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20

Wearable Artificial Kidney – Product Status 20

Wearable Artificial Kidney – Product Description 20

Chemica Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Portable Hemodialysis System – Product Status 21

Portable Hemodialysis System – Product Description 21

CVS Kidney Care Pipeline Products & Ongoing Clinical Trials Overview 22

HemoCare Hemodialysis System – Product Status 22

HemoCare Hemodialysis System – Product Description 22

CVS Kidney Care – Ongoing Clinical Trials Overview 23

HemoCare Hemodialysis System – An Open Label Study to HemoCare Hemodialysis System for Home Hemodialysis Prior to Market Authorization 24

HemoCare Hemodialysis System – Clinical Evaluation of the HemoCare Hemodialysis System for Home Nocturnal Hemodialysis 24

Diality Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Dharma – Product Status 25

Dharma – Product Description 25

Fresenius Medical Care Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Hospital Renal Replacement Device – Product Status 26

Hospital Renal Replacement Device – Product Description 26

Portable Table Top HD Machine – Product Status 27

Portable Table Top HD Machine – Product Description 27

Wearable Artificial Kidney – Product Status 27

Wearable Artificial Kidney – Product Description 28

XCR-6 – Product Status 28

XCR-6 – Product Description 28

Gambro Dasco SpA Pipeline Products & Ongoing Clinical Trials Overview 29

Artis Dialysis System – Product Status 29

Artis Dialysis System – Product Description 29

Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 30

Pediatric Renal Dialysis Device – Product Status 30

Pediatric Renal Dialysis Device – Product Description 30

Portable Renal Replacement System – Product Status 31

Portable Renal Replacement System – Product Description 31

Infomed SA Pipeline Products & Ongoing Clinical Trials Overview 32

DIMI Home Hemodialysis Device – Product Status 32

DIMI Home Hemodialysis Device – Product Description 32

Infomed SA – Ongoing Clinical Trials Overview 33

DIMI Home Hemodialysis Device – A Prospective Multicenter, Open Label, Non-randomized, Cross-over Study Evaluating the Use of the DIMI Renal Replacement Therapy (RRT) System In-center by Trained Dialysis Nurses and In-home by Trained Care Partners and Patients with End Stage Renal Disease (ESRD) Who are on Stable Dialysis Regimens 34

Iowa State University Pipeline Products & Ongoing Clinical Trials Overview 35

Wearable Artificial Kidney – Product Status 35

Wearable Artificial Kidney – Product Description 35

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 36

HDS – Hemodialysis System – Product Status 36

HDS – Hemodialysis System – Product Description 36

Nanodialysis BV Pipeline Products & Ongoing Clinical Trials Overview 37

Portable Hemodialysis Device – Product Status 37

Portable Hemodialysis Device – Product Description 37

Neokidney Development BV Pipeline Products & Ongoing Clinical Trials Overview 38

Neokidney 2.0 – Product Status 38

Neokidney 2.0 – Product Description 38

Nephria Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 39

EOCARRT – Product Status 39

EOCARRT – Product Description 39

Nikkiso Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

Artificial Kidneys – Product Status 40

Artificial Kidneys – Product Description 40

Next Generation Dialysis Machine – Product Status 41

Next Generation Dialysis Machine – Product Description 41

NxStage Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Next Generation Critical Care System – Product Status 42

Next Generation Critical Care System – Product Description 42

Physiologas Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Home Dialysis Machine – Product Status 43

Home Dialysis Machine – Product Description 43

Quanta Dialysis Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

Advanced Haemodialysis System – Nocturnal Use – Product Status 44

Advanced Haemodialysis System – Nocturnal Use – Product Description 44

University of Rostock Pipeline Products & Ongoing Clinical Trials Overview 45

Wearable Artificial Kidney – Product Status 45

Wearable Artificial Kidney – Product Description 45

University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview 46

Portable Artificial Kidney – Product Status 46

Portable Artificial Kidney – Product Description 46

Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 47

Hemocartridge – Product Status 47

Hemocartridge – Product Description 47

Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Wearable Artificial Kidney – Product Status 48

Wearable Artificial Kidney – Product Description 48

Vizio Medical Devices Pipeline Products & Ongoing Clinical Trials Overview 49

Ambulatory Wearable Device – Product Status 49

Ambulatory Wearable Device – Product Description 49

Wearable Artificial Organs Inc Pipeline Products & Ongoing Clinical Trials Overview 50

Wearable Artificial Kidney (WAK) 3.0 – Product Status 50

Wearable Artificial Kidney (WAK) 3.0 – Product Description 50

Figures

Hemodialysis Machines – Pipeline Products by Stage of Development 9

Hemodialysis Machines – Pipeline Products by Segment 10

Hemodialysis Machines – Pipeline Products by Territory 11

Hemodialysis Machines – Pipeline Products by Regulatory Path 12

Hemodialysis Machines – Pipeline Products by Estimated Approval Date 13

Frequently asked questions

Hemodialysis Machines Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Hemodialysis Machines Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Hemodialysis Machines Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

  • Access a live Hemodialysis Machines Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.